X-linked severe combined immunodeficiency

Newborn screening is performed within the first 24–48 hours of life as part of routine panels. The test measures T‑cell receptor excision circles (TRECs) by PCR from a heel‑stick blood spot. A low or absent TREC result triggers confirmatory flow‑cytometry or genetic testing for IL2RG mutations. Parents should inform the lab that the baby is male and discuss follow‑up steps.;If my baby tests positive for X‑linked SCID, what immediate steps should the medical team take to prevent life‑threatening infections?::The first priority is to isolate the infant from potential pathogens and start prophylactic antibiotics (e.g., trimethoprim‑sulfamethoxazole) and antifungal agents (e.g., fluconazole). A hematopoietic stem‑cell transplant (HSCT) is the definitive cure and is usually performed before 3–6 months of age. In the interim, the baby receives intravenous immunoglobulin (IVIG) every 3–4 weeks to provide passive antibodies.;What lifestyle or dietary changes can help a child with X‑linked SCID stay healthy while awaiting transplant?::Strict infection control is key: keep the child away from crowds, avoid raw or unpasteurized foods, and ensure all caregivers are vaccinated against influenza and COVID‑19. Use a HEPA filter in the bedroom, wash hands frequently, and consider a dedicated room for the child. Nutritionally, a balanced diet with adequate calories and protein supports growth; a pediatric dietitian can tailor a plan if the child has chronic diarrhea.;How will my family plan for future pregnancies if one of our children has X‑linked SCID?::Genetic counseling is essential. A carrier test for the IL2RG mutation can be offered to the mother and any male relatives. Prenatal testing via chorionic villus sampling (10–12 weeks) or amniocentesis (15–18 weeks) can detect the mutation in the fetus. Pre‑implantation genetic diagnosis (PGD) during IVF allows selection of embryos without the mutation.